Ardsley Advisory Partners LP Amicus Therapeutics, Inc. Transaction History

Ardsley Advisory Partners LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $202,050 - $373,350	-15,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $3.09 Million - $3.81 Million	-240,000 Reduced 94.12%	15,000 $212,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $2.26 Million - $4 Million	255,000 New	255,000 $3.85 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $180,450 - $298,125	-22,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $27,400 - $36,000	2,500 Added 12.5%	22,500 $281,000
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $1.96 Million - $2.71 Million	-195,000 Reduced 90.7%	20,000 $272,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $2.47 Million - $3.96 Million	-295,000 Reduced 57.84%	215,000 $2.06 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $58,000 - $82,700	5,000 Added 0.99%	510,000 $6.17 Million
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $919,100 - $1.2 Million	70,000 Added 16.09%	505,000 $7.89 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.44 Million - $1.8 Million	105,000 Added 31.82%	435,000 $6.54 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $437,850 - $568,400	-35,000 Reduced 9.59%	330,000 $4.75 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $4.29 Million - $5.76 Million	365,000	365,000 $5.5 Million

309

283M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.92B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.